Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

ASTRO planning its 2004 IMRT Practicum

The American Society of Therapeutic Radiology and Oncology (ASTRO) 2004 IMRT Practicum is scheduled for Feb. 6 to Feb. 8 at the Paradise Point Resort & Spa in San Diego.

InSiteOne's new product focused on disaster recovery

Addressing the need for disaster recovery for hospitals and imaging clinics, InSiteOne introduces InDex Recovery.

Kodak gets FDA nod for CAD product

Eastman Kodak has received FDA approval for a mammography computer-aided detection (CAD) device.

... while von Pierer says he plans to stay awhile

Siemens AG Chief Executive Heinrich von Pierer emphasized that he plans to stay with the company beyond the end of his current contract, which expires in September 2004.

Kleinfeld to take Siemens' Worldwide Communications post

Klaus Kleinfeld, president and CEO of U.S. operations for Siemens AG, is heading to a new assignment.

Sectra receives order for breast imaging PACS in Norway

Swedish IT and medical company Sectra will install its breast imaging PACS (picture archiving and communications systems) at Brystsentrum, a breast screening center in Tonsberg, Norway.

Toshiba agrees to three-year pact with Iowa Health System

Toshiba America Medical Solutions has signed a three-year contract with Iowa Health System to provide health imaging systems - including CT, MRI, both conventional and vascular X-ray, ultrasound and nuclear medicine modalities.

R2 Technology to distribute MRS' mammography reporting software

R2 Technology Inc. and Mammography Reporting System Inc. (MRS) have signed a three-year distribution agreement for the MRS Mammography Reporting System.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.